Featured Posts
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Search Posts
Hoover Institution
Free Speech for Big Pharma
One of the most important elements of medicine is also among the least well known: the ability of physicians to prescribe approved medicines for purposes…
Hoover Institution
A Lack of Government Transparency: The Devil In The Detailing
Cowritten by Jeff Stier. A House Appropriations subcommittee has voted to move forward legislation that would cut $1.3 billion from the Department of Health and…
Orange County Register
A Losing Proposition on Food Labeling
California's initiative process – which allows "propositions" to be placed on the ballot quite easily – can lead to laws that are muddled, intentionally misleading…
Orange County Register
A Conservative Case for Obamacare?
From Thomas P. Miller’s column in National Review: The response of roughly half of the Senate Republicans was to co-sponsor an alternative bill…
Forbes
Labeling Of Genetically Engineered Foods Is A Losing Proposition
As Joe Six-pack munches Fritos and popcorn during the opening games of the NFL season, does he care what variety of corn was used to…
Boston Herald
Mass. biotech reaps Monsanto deal
From Ira Kantor's article in The Boston Herald: Gregory Conko, senior fellow at the Competitive Enterprise Institute in Washington, D.C., and co-author of…